Net shares · 365d
+270.2K
270.2K buy · 0 sell
Net value · 365d
$773.5K
$773.5K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
4
270.2K buy · 0 sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
GRVI Buy·P
Director
$127.5K
50.0K sh · $2.55
Own +30%
-
GRVI Buy·P
Director
$546.0K
200.0K sh · $2.73 avg · 2 lots
Own +54%
-
GRVI Buy·P
Director,TenPercentOwner
$100.0K
20.2K sh · $4.94
Own +6%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Nov 20, 2025 | GRVI | Buy P | 50.0K | $127.5K |
| Nov 17, 2025 | GRVI | Buy P | 200.0K2 lots | $546.0K |
| Jul 11, 2025 | GRVI | Buy P | 20.2K | $100.0K |
Buy Sell Non-market (grant · exercise · gift)
About Salkind Gene
This profile aggregates every SEC Form 4 insider transaction reported by Salkind Gene across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.